Evidence map›Paper›PMID 28594570›Full record

Observational studyAmerican journal of respiratory and critical care medicine2017

Obstructive Sleep Apnea and Retinopathy in Patients with Type 2 Diabetes. A Longitudinal Study.

Quratul A Altaf, Paul Dodson, Asad Ali, Neil T Raymond, Helen Wharton, Hannah Fellows, Rachel Hampshire-Bancroft, Mirriam Shah, Emma Shepherd, Jamili Miah and 2 more

Registry-linked trialOpen access · greenAbstract readObservational Study
In one paragraph

Observational study in American journal of respiratory and critical care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03314467 (Role of Obstructive Sleep Apnea Syndrome in the Occurrence of Diabetic Retinopathy in Type 2 Diabetes.), which is not on this map. Cited by 53 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 4 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03314467 completednot on this map

Role of Obstructive Sleep Apnea Syndrome in the Occurrence of Diabetic Retinopathy in Type 2 Diabetes.

TypeobservationalSponsorCentre Hospitalier Universitaire Saint PierreRan2017 to 2021Enrolled60ConditionsDiabetes Mellitus, Obstructive Sleep ApneaArmspolysomnography
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 4 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Validation of the STOP questionnaire as a screening tool for OSA among different populations: a systematic review and meta-regression analysis.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Pooled it
  4. Sleep apnea and eye diseases: evidence of association and potential pathogenic mechanisms.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Pooled it
  5. The impact of obstructive sleep apnea treatment on microvascular complications in patients with type 2 diabetes: a feasibility randomized controlled trial.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Trial
  6. Trial
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Neuro-Ophthalmological Disorders Associated with Obstructive Sleep Apnoea.International journal of molecular sciences · 2025
    Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Quratul A Altaf1 Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Paul Dodson3 Department of Diabetes and Endocrinology and.
Asad Ali6 Department of Respiratory Medicine, University Hospital of Coventry and Warwickshire, Coventry NHS Trust, United Kingdom; and.
Neil T Raymond7 Epidemiology, Research Design and Statistical Consulting (ERDASC), Leicestershire, United Kingdom.
Helen Wharton3 Department of Diabetes and Endocrinology and.
Hannah Fellows3 Department of Diabetes and Endocrinology and.
Rachel Hampshire-Bancroft3 Department of Diabetes and Endocrinology and.
Mirriam Shah3 Department of Diabetes and Endocrinology and.
Emma Shepherd3 Department of Diabetes and Endocrinology and.
Jamili Miah3 Department of Diabetes and Endocrinology and.
Anthony H Barnett1 Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Abd A Tahrani1 Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0001-9037-1937
Heart of England NHS Foundation Trust · GBUniversity of Birmingham · GBAston University · GBStatistical Research (United States) · USUniversity Hospital Coventry · GB

Funding

Department of Health CS-2013-13-029Department of Health RTF/01/094
6 · The paper itself

Abstract

rationaleObstructive sleep apnea (OSA) is associated with several pathophysiological deficits found in diabetic retinopathy (DR). Hence, it's plausible that OSA could play a role in the pathogenesis of sight-threatening DR (STDR).

objectivesTo assess the relationship between OSA and DR in patients with type 2 diabetes and to assess whether OSA is associated with its progression.

methodsA longitudinal study was conducted in diabetes clinics within two U.K. hospitals. Patients known to have any respiratory disorder (including OSA) were excluded. DR was assessed using two-field 45-degree retinal images for each eye. OSA was assessed using a home-based multichannel cardiorespiratory device. MEASUREMENTS AND MAIN

resultsA total of 230 patients were included. STDR and OSA prevalence rates were 36.1% and 63.9%, respectively. STDR prevalence was higher in patients with OSA than in those without OSA (42.9% vs. 24.1%; P = 0.004). After adjustment for confounders, OSA remained independently associated with STDR (odds ratio, 2.3; 95% confidence interval, 1.1-4.9; P = 0.04). After a median (interquartile range) follow-up of 43.0 (37.0-51.0) months, patients with OSA were more likely than patients without OSA to develop preproliferative/proliferative DR (18.4% vs. 6.1%; P = 0.02). After adjustment for confounders, OSA remained an independent predictor of progression to preproliferative/proliferative DR (odds ratio, 5.2; 95% CI confidence interval, 1.2-23.0; P = 0.03). Patients who received continuous positive airway pressure treatment were significantly less likely to develop preproliferative/proliferative DR.

conclusionsOSA is associated with STDR in patients with type 2 diabetes. OSA is an independent predictor for the progression to preproliferative/proliferative DR. Continuous positive airway pressure treatment was associated with reduction in preproliferative/proliferative DR. Interventional studies are needed to assess the impact of OSA treatment on STDR.

Indexed as

Cross-Sectional StudiesDiabetes Mellitus, Type 2Diabetic RetinopathyDisease ProgressionFemaleHumansLongitudinal StudiesMaleMiddle AgedOdds RatioSleep Apnea, ObstructiveUnited Kingdomdiabetic retinopathymaculopathyobstructive sleep apnea

Identifiers

PMID28594570
PMCPMC5649977
OpenAlexW2623048247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.